FDA Grants Regenerative Medicine Advanced Therapy (RMAT) designation to Autolus' CAR T cell therapy, obe-cel, for the treatment of adult B-ALLGlobeNewsWire • 04/25/22
Autolus Therapeutics to Report First Quarter 2022 Financial Results and Host Conference Call on May 5GlobeNewsWire • 04/25/22
Autolus Therapeutics Receives EMA Orphan Medical Product Designation for obe-cel for Treatment of Acute Lymphoblastic LeukemiaGlobeNewsWire • 03/31/22
Autolus Therapeutics plc (AUTL) CEO Dr. Christian Itin on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/10/22
Autolus Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Operational ProgressGlobeNewsWire • 03/10/22
Autolus Therapeutics Announces Publication Describing Novel Cell Programming TechnologyGlobeNewsWire • 03/03/22
Autolus Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on March 10GlobeNewsWire • 02/21/22
Autolus Therapeutics PLC Sponsored ADR (AUTL) Loses 22.1% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 01/19/22
Autolus Therapeutics announces retirement of chief financial officer and succession planGlobeNewsWire • 01/10/22
Autolus Therapeutics presents positive obe-cel data at the 63rd ASH Annual Meeting & ExpositionGlobeNewsWire • 12/13/21
Autolus Therapeutics announce new time for investor call to discuss data presented at the 63rd ASH Annual Meeting & ExpositionGlobeNewsWire • 12/06/21
Autolus Therapeutics announces the appointment of Dr. William D. Young as a Non-Executive DirectorGlobeNewsWire • 11/15/21
Autolus Therapeutics announces publication describing its small molecule-regulated CAR T cellsGlobeNewsWire • 11/10/21
Market Highlights: Stocks react to earnings release, Blackstone invests $250 billion in Autolus, Elon Musk to sell 10% Tesla stakeInvezz • 11/09/21
Blackstone Life Sciences to invest up to $250 million in Autolus Therapeutics to develop obe-cel in adult Acute Lymphoblastic Leukemia (ALL) and advance broader platformGlobeNewsWire • 11/08/21
The Wall Street Journal: Blackstone to invest up to $250 million in British biotech company AutolusMarket Watch • 11/08/21
Autolus Therapeutics to Present New Data at the 63rd ASH Annual Meeting & ExpositionGlobeNewsWire • 11/04/21
Autolus Therapeutics plc (AUTL) CEO Dr. Christian Itin on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/04/21